Jun 25, 2023 / 08:00PM GMT
Ryan Weispfenning - Medtronic plc - VP & Head of IR
Okay. Good afternoon, everyone. I'm Ryan Weispfenning, Vice President, Head of Medtronic Investor Relations, and thank you for joining us for our Diabetes Analyst and Investor Briefing here live from the American Diabetes Association 83rd Scientific Sessions. It's great to see all of you in the room and be here in person with all of you. And then I also want to welcome those joining us around the world on the webcast today.
Get to the next slide. There we go. During today's program, many of the statements we make may be considered forward-looking statements, and actual results might differ materially from those projected in any forward-looking statement. Additional information concerning factors that could cause actual results to differ is contained in our periodic reports and other filings that we make with the SEC, and we do not undertake to update any forward-looking statement. I encourage you to go back and read this slide.
The slides we're presenting today will be made available on our website at investorrelations.medtronic.com
Medtronic PLC Investor Briefing Transcript
Jan 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers